Report Publication Announcement • Feb 23, 2023
Report Publication Announcement
Open in ViewerOpens in native device viewer
Medistim to host a Capital Markets Day on Tuesday 21st of March 2023
(Oslo, 23rd February 2023) Medistim ASA (OSE: MEDI) is a niche market leader within ultrasound technology with headquarters in Oslo, Norway. Medistim develops and commercializes medical equipment for use within cardiac, vascular and transplant surgery. Today, the company announces that they will hold a Capital Markets Day at Grand Hotel, Oslo, on March 21st from 9 am to 11 am. Breakfast will be served from 8:30.
Medistim is proud to announce that one of the world’s leading cardiac surgeons, Professor John D. Puskas of Mount Sinai Health System, New York, is joining us to talk about the past, present, and future of Coronary Artery Bypass (CABG) surgery, the need for innovation and Medistim’s role in this. Dr. Puskas is internationally recognized for his expertise in off-pump CABG and has performed more than 5000 off-pump procedures since 1996. He is a global leader in the development of minimally invasive Hybrid Coronary Revascularization, which combines robotic bypass grafting with catheter-based stents in selected patients. Dr. Puskas was also one of the lead investigators on the REQUEST study, a multicenter, prospective study on the influence of Medistim’s Transit Time Flow Measurement and High Frequency Ultrasound Imaging system in >1000 patients, published in the Journal of Thoracic and Cardiovascular Surgery 2020.
In addition, we are delighted that Chief Physician in Vascular Surgery, Professor Pirkka Vikatmaa, Helsinki University Hospital, Finland, will enlighten us on the need and future for open vascular surgery procedures, and the importance of quality assessment and surgical guidance during these procedures. Dr. Vikatmaa was previously on the board of the European Society of Vascular Surgery (ESVS) and is currently President of the Finnish Surgical Society.
“We look forward to welcoming current and new shareholders to learn more about the fundamentals in Medistim’s addressable markets, directly from the thought leaders in this space,” says Medistim President and CEO, Kari E. Krogstad. “In addition, we will provide a company update, including some direction for our product innovation. We hope to see you there!”
About Medistim:
Medistim was established in 1984 and has a track record of profitable growth over the past 20 years. The company is a pioneer within its segment and continues to invest in new product development. Medistim has wholly owned subsidiaries with sales organizations in the USA, Germany, UK, Spain, Denmark, and Norway, in addition to the about 50 distributors in Europe, Asia, Middle East, Africa, Canada and South America. For more information, visit the Medistim home page: www.medistim.com
Please register your participation on the following link:
https://conta.cc/3ExdsWq
For more information, contact:
President and CEO, Kari E. Krogstad, Medistim ASA
Tel: + 47 918 38 110
Email: [email protected]
CFO, Thomas Jakobsen, Medistim ASA
Tel: + 47 906 59 940
Email: [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.